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A 40-day-old infant weighing 3.5 kg was referred to the Department of Paediatric Surgery at Pandit Bhagwat Dayal Sharma 
Post Graduate Institute of Medical Sciences, Rohtak, 
Haryana, India, in 2016 with swelling of the left 
hand since birth. The swelling was soft, oval and 
approximately 9 × 7 cm in size starting from the 
base of the hand proximally and extending up to the 
distal interphalangeal joints [Figure 1]. The size of 
swelling had progressively increased since birth. Due 
to the large size of the swelling, movement of the 
wrist joint was restricted and the hand was grossly 
deformed. An X-ray of the lesion revealed a soft 
tissue swelling with multiple calcifications. Absolute 
platelet count and coagulation profile were within 
normal ranges; abdominal ultrasound and chest X-ray 
were unremarkable. With the differential diagnosis of 
giant vascular malformation, infantile haemangioma 
and tufted angioma involving proximal part of all 
fingers, palmer and dorsal surface of the hand, further 
interventions were planned. However, the parents 
chose to discharge the infant against medical advice.
Comment
The diagnosis of vascular lesions such as infantile 
haemangioma, Kaposiform haemangioendothelioma 
(KHE), tufted angioma (TA) and vascular malform- 
ations are usually established by clinical features, 
radio-imaging and immunohistochemical markers.1 
Benign vascular neoplasm KHE has a wider age of 
presentation then infantile haemangioma. Similarly, 
TA presents in infants, children or young adults and 
are usually located on the neck or the upper part of the 
thorax. Both, KHE and TA have glucose transporter 
protein isoform (GLUT1) negative endothelial cells and 
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Figure 1: Photographs of the hand of a 40-day-old infant showing the (A) palmer and (B) dorsal aspect of a haemangioma.
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may be associated with thrombocytopaenia. Vascular 
malformations are congenital lesions that sometimes 
become apparent later in life and do not involute 
spontaneously. Haemangiomas are the most common 
benign soft tissue tumours in infants, found in 4–10% 
with higher female preponderance.2 Haemangiomas 
are seen most commonly in the craniofacial region 
(60%), followed by the trunk (25%) and extremities 
(15%). Immunohistochemical markers such as GLUT1 
can be useful for differentiating haemangiomas from 
other vascular lesions.3 After a rapidly proliferative 
phase during the early infantile period, most 
uncomplicated lesions undergo spontaneous slow 
involution and an active non-intervention approach 
may be preferred.4 However, some children require 
further intervention due to associated complications. 
Therapeutic interventions are based on the 
location, size of haemangioma, age of the patient, 
presence of complications and experts’ and parents’ 
preferences. Beta-blockers (e.g. oral propranolol) 
haveshown promising results in uncomplicated haeman- 
giomas; however, detailed cardiovascular and respiratory 
evaluation is required before initiating these drugs.5 
Oral propranolol therapy is usually given for 6–12 
months depending on the size and location of the 
lesion. 
In recent years, the use of corticosteroids to treat 
haemangiomas has decreased and is only used when 
beta-blockers are contraindicated.4 Other medications 
such as vincristine, interferon-α and imiquimod may 
be useful but are rarely used due to their serious side- 
effects. Recently, the common antifungal agent itraco- 
nazole has been found to be useful in the treatment of 
infantile haemangioma by inhibiting proliferation and 
promoting apoptosis of infantile primary haeman- 
gioma endothelial cells.6
In addition to pharmacological treatment, laser 
therapy and surgical interventions are alternative 
treatment options. Although pulsed-dye laser treat- 
ment has debatable efficacy, they may be used on 
superficial lesions.7 Excisional surgery may be under- 
taken when the haemangioma causes visual or sub- 
glottic obstruction, bleeding or recurrent ulceration as 
well as slow involution or failure of pharmacological 
treatment.5
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